• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Navigating GLP-1 Medications: Prior Authorization Challenges and Solutions

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles The expert explored the complex prior authorization process for GLP-1 medications, discussing challenges in documentation and medical necessity. Read More

Phase 3 Trial Explores Imetelstat for Advanced Myelofibrosis After Promising Phase 2 Data

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles Imetelstat shows promise in treating myelofibrosis, enhancing survival, and modifying disease biology in patients resistant to JAK inhibitors. Read More

Five-Year Follow-Up Data Shows Zanubrutinib Improves Progression-Free Survival, Overall Survival in CLL/SLL

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles The data from the phase 3 SEQUOIA study are to be presented at the 2025 ASCO Annual Meeting. Read More

WEHI-3773 May Be Leveraged to Develop Therapeutic Strategies for Neurodegenerative Conditions

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles The small molecule effectively blocks cell death effector proteins, potentially rescuing cells from degeneration. Read More

Health Care Is a Human Right: A Roundtable on Values, Visibility, and the Work Ahead

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles In this roundtable, 3 pharmacy faculty members reflect on how shifting federal priorities and the defunding of research initiatives have impacted their work, communities, and careers—while highlighting the power of resilience,...

CDC to End COVID-19 Vaccine Recommendation for Healthy Children, Pregnant Women

by MM360 Staff | May 27, 2025 | Myeloma News

Source: Pharmacy Times articles The change is poised to impact countless individuals who may have sought out a COVID-19 vaccine this upcoming respiratory season. Read More
« Older Entries
Next Entries »

Recent Content

  • Glioma trial of intranasal therapy NEO100 fills all patient slots
  • WHO grants nonproprietary name to ovarian cancer cell therapy
  • Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
  • Carvykti label updated to include survival benefit data in myeloma
  • Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis
  • FDA approves ziftomenib to treat some relapsed leukemia patients
  • (no title)
  • The challenge of non-transplant eligible, newly diagnosed multiple myeloma
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT